Fmoc-alpha-Me-D-Leu-OH

Fmoc-alpha-Me-D-Leu-OH is a chiral, N-Fmoc-protected amino acid derivative in which the D-leucine stereocenter is retained and the alpha-carbon bears a methyl substituent, yielding an α-methyl, conformationally biased residue. The molecule contains a fluorenylmethoxycarbonyl (Fmoc) carbamate on the amino group and a free carboxylic acid, enabling controlled peptide coupling at the C-terminus while remaining compatible with standard Fmoc deprotection chemistry. The side chain of leucine provides a hydrophobic isobutyl group that participates in peptide secondary-structure stabilization and hydrophobic packing, while the α-methyl group can influence backbone torsion angles and protease recognition. As a protected amino acid building block, Fmoc-alpha-Me-D-Leu-OH behaves as a stable chiral intermediate for peptide synthesis and downstream derivatization where stereodefined, non-proteinogenic residues are required.

1. Fmoc Peptide Synthesis

Fmoc-alpha-Me-D-Leu-OH is used in Fmoc-based solid-phase peptide synthesis and solution-phase peptide coupling where a D-configured, α-methyl leucine residue is required to modulate backbone conformation. The Fmoc carbamate protects the N-terminus during chain assembly and can be removed under base conditions to expose the amino group for sequential coupling, while the free carboxylic acid supports activation and amide bond formation. The α-methyl substitution and D stereochemistry can be leveraged to tune steric profiles and reduce conformational flexibility relative to standard leucine, enabling construction of peptide analogs with altered folding propensity. The resulting peptide products can serve as research-grade scaffolds for studying how stereochemistry and α-substitution influence stability and sequence-dependent structure.

2. Peptidomimetics And SAR Studies

Fmoc-alpha-Me-D-Leu-OH is applied in peptidomimetic design and structure-activity relationship studies where incorporation of an α-methyl, D-amino acid residue is used to probe structure-function relationships. The leucine side chain contributes hydrophobic surface area, and the α-methyl group can shift local backbone geometry, which may affect receptor binding motifs and proteolytic susceptibility in peptide-like ligands. Fmoc protection enables stepwise assembly of analog series with consistent stereochemical identity at the modified residue position, supporting systematic SAR comparisons across analog libraries. Downstream, peptides containing this residue can be further functionalized at other positions for conjugation or for generating constrained analogs used in medicinal chemistry research workflows.

3. Unnatural Amino Acid Incorporation

Fmoc-alpha-Me-D-Leu-OH is suitable for unnatural amino acid incorporation strategies in chemical biology and protein engineering tool development where non-natural stereochemistry is used to control molecular recognition. The compound's D configuration and α-methyl substitution provide a chiral, sterically defined building block that can be incorporated into peptides and peptide-derived probes to alter binding specificity and conformational preferences. The preserved carboxylic acid functionality supports coupling to activated amino acid derivatives or peptide fragments, while the Fmoc group provides orthogonal handling during synthesis and allows selective incorporation into defined sequences. The resulting modified biomolecules can be used as chemically defined standards for evaluating how backbone modification affects ligand presentation, enzyme tolerance, or binding-site compatibility in experimental assays.

4. Side-Chain Functionalization Intermediates

Fmoc-alpha-Me-D-Leu-OH serves as an amino acid-based intermediate for generating functionalized derivatives that retain a protected peptide-compatible backbone. The molecule's leucine-derived hydrophobic side chain can be carried through synthesis as a stable handle for later transformations, while the free carboxylic acid enables conversion to activated esters, amides, or coupling partners for attaching linkers and reporter groups. The α-methyl, D stereocenter can be maintained through derivative formation to preserve stereochemical integrity in downstream constructs. Functionalized derivatives derived from this building block can support linker engineering in bioconjugation chemistry, preparation of constrained peptide probes, and synthesis of intermediate fragments used in fine chemical manufacturing routes.

5. Chiral Building Block Manufacturing

Fmoc-alpha-Me-D-Leu-OH is applicable to process chemistry and specialty chemical production as a stereodefined chiral amino acid intermediate for peptide manufacturing workflows. The presence of an Fmoc-protected amine and a free carboxylic acid provides a clear functional-group pattern for designing robust upstream and downstream steps, including controlled protection/deprotection logic and predictable coupling behavior during peptide assembly. The α-methyl substitution and D stereochemistry make it a targeted chiral input for producing non-natural residue-containing peptide intermediates used in industrial peptide development pipelines. The compound can be employed in the preparation of defined protected amino acid lots and intermediate streams that feed into automated peptide synthesizers and related chemical manufacturing processes.

6. Analytical Standards And Method Development

Fmoc-alpha-Me-D-Leu-OH is used in analytical research and method development for characterizing peptide synthesis, monitoring incorporation of α-methyl, D-amino acid residues, and supporting LC-MS or HPLC method tuning. The Fmoc group provides a strong chromophore for UV-based detection, while the defined stereochemistry and α-methyl substitution create a characteristic mass signature that can be tracked in peptide fragments and deprotected intermediates. The free carboxylic acid enables conversion into reference derivatives that match expected coupling states, improving interpretability of chromatographic behavior across synthetic stages. Reference materials derived from this building block can support quality control of peptide building block preparation and verification of stereochemical identity in research and industrial peptide workflows.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides